Theaimofthestudywastoassesstherelationshipbetweentheapparentdiffusion coefficientindiffusion-weightedmagnetic(DWM)resonanceimaging(MRI)and selected morphological parameters of the breast lesions. Diffusion-weighted imaging data and the pathology reports of 160 women treated surgically between January2011andMarch2015wereanalyzed.Whenclassified,107invasivecar-cinomas, 13 pre-invasive carcinomas and 40 benign lesions were identified. The meanapparentdiffusioncoefficientwassignificantlylowerforinvasivecarcinomas thanbenignlesionsofthebreast(0.87±0.02vs.1.58±0.04;p<0.001).What ismoretherewasaninversecorrelationbetweenvalueofapparentdiffusioncoefficientindiffusion-weightedmagneticresonanceimagingandthegradeofbreast carcinomas(p =0.04).
Introduction
Diffusion-weighted imaging (DWI) represents oneofthelatestdevelopmentsinmagneticresonance imaging (MRI). This method is based on the idea thatthemovementofwatermoleculesintheextracellularfluidmayreflectthehistologicalstructureof thetissue [1, 2] .UsingDWIsequences,theapparent diffusion coefficient (ADC), which is a quantitative measure of the restriction of water molecule movementwithinadefinedarea,canbecalculated.Several studieshavedemonstratedthattheADCreflectscell density and can be used to differentiate malignant from benign lesions within a multitude anatomical locations. High cellular proliferation increases the tissuedensityandmayrestrictthemovementofextracellular fluid due to the formation of additional barriers;subsequently,adecreaseinimagesignalintensityandalowerADCcanbeobserved [3, 4, 5] . Sofar,alimitednumberofindependentstudieshave concluded that ADC evaluation allows for benign tumors to be distinguished from malignant lesions withinthebreastwithhighspecificity.
Histopathological features of malignant lesions ofthebreastareamongthemajordeterminantsof clinical outcomes. Moreover, crucial post-surgery decisions concerning adjuvant therapy, as well as follow-up strategy, are based on the clinicopathological characteristics of the resected lesions. The purposesofourstudywereto:(1)confirmtheefficacyofusingDW-MRI-basedADCtodifferentiate benign from malignant lesions within the breast; and, (2) determine the relationship between ADC and the major histopathological parameters (grading and morphology) in the most common breast carcinomas.
Material and methods
ThestudywasperformedattheMariaSklodowska-Curie Memorial Cancer Center and Institute of Oncology, Cracow Branch, Poland, between January1,2011andMarch31,2015.Onehundredand sixty women aged 18-89 years (median: 55.5 years old),whowerediagnosedandtreatedinthehospital duringthistime,underwentbreastMRIwithDWI. AllMRIexaminationswerecarriedoutusingthe SiemensMagnetomAvanto1.5-Twhole-bodyscanner with a dedicated phased-array bilateral breast coil. During the MRI, patients were required to lie prone, facing downwards, and a dedicated breast holder was used to eliminate motion artifacts [6] . The imaging protocol included the following resonance sequences: TSE-T1, transverse (for approximately2minand13s);TSE-T2,transverse(2min and37s);TSE-T2STIR,transverse(2minand33s); DWI/ADC EP 2D, transverse (diffusion imaging; 5minand59s);andTSE-T1FL3D,FATSAT,transverse, dynamic (after intravenous contrast infusion; sequenceswererepeatedfor7minat1-minintervals). Thegadobutrol(Gadovist®)contrastagentwasadministeredintravenously,atadoseof0.1mmol/kg, usingadedicatedinfusionpumpwitha2-ml/second flowrate.TheanalysiswasconductedusingtheBreVissoftware(SyngoViaVA20B,Siemens,2013).All patientswhowereenrolledinthestudywerepreviouslydiagnosedwithasuspiciousbreastlesion,and subsequentdecisionsconcerningsurgicalapproaches and adjuvant strategies were to be made based on the MRI findings. The DWI evaluation was based onasubjectiveestimationofbrightnessintheDWI sequence along with the corresponding map distributioninrelationtothebackground.TheADCwas calculatedafterwards.Themeasurementsweremade using the dedicated functionality within the BreVis software,inanareaapproximately0.5cm
Thehistopathologyreportsoftheresectedspecimenswereusedasareferenceforradiological-pathological comparisons. Highly trained pathologist, in accordancewiththemostrecentclassifications,carried out the microscopic examinations. The 2012 World Health Organization classification was used for malignant neoplastic lesions [7] ; whereas, for invasive carcinomas, tumors were graded according to the Elston-Ellis modification of the Bloom-Richardson grading system (Bloom-Richardson-Elston gradingsystem) [8] a sensitivity of 95%, a specificity of 100%, and an accuracyof96%. Eighty-nineinvasivecarcinomaswereclassifiedaccordingtotheBloom-Richardson-Elstongradingsystem.Eleven(12%)welldifferentiated(G1),48(54%) moderatelydifferentiated(G2),and30(34%)poorly differentiated carcinomas (G3) were identified. The mean ADC values, according to the grading scores of invasive carcinomas, are presented in Table II . ThedifferencebetweenthemeanADCvaluesofthe G1 and G3 grading categories proved statistically significant(p=0.01).
Discussion
According to the College of American Pathologists (1999), the prognostic factors in breast carcinomaaredividedintothreegroups:categoriesI, IIandIII.TheprognosticvalueofcategoryI(e.g., TNMstaging,histologicalgrade,histologicaltype, mitoticfigurecount,andhormonereceptorstatus) hasbeenprovenunequivocally;whereas,categories II and III consist of factors that, although having been studied extensively, still require further validation (category II) or have not been studied suf- ficiently (category III) [9] . In our study, defined prognosticfactorswereusedforradiological-pathological assessment and comparison. In particular, histological type and histological grade were used (whenapplicable)duetotheircloserelationshipto tissue density and other biophysical features. Increased cellularity of invasive carcinomas, when comparedtobenignlesionsofthebreast,resultedin adecreasedmeanADCinMRI.Thisresultisinline withpreviousreportsconcerningsuchrelationships. AccordingtoLuoet al.,DW-MRIishelpfulindifferentialdiagnosesofbreastdiseases [10] .
Breastlesionsmayoccasionallybedifficulttodiagnoseradiologically,especiallyindensefibro-glandularbreasts.Overrecentyears,MRIhasbeenincreasinglyusedinthescreeningofhigh-riskindividuals, as well as in a routine breast evaluation. Dynamic MRI studies improve the detection and characterizationofproblematiclesionsinthebreast;however, thelowspecificityofMRIremainsalimitation [11] . ItisthereforenosurprisethatDWI,basedonalterationsinthemicroscopicmotionofwatermolecules, has become widely used in MRI. It is thought that themovementofwatermoleculesintheextracellular fluid reflects the histological or even molecular /s), withasensitivityof95%,aspecificityof100%,and anaccuracyof96%.
Inthepresentstudy,160womenwithbreastle-sions initially detected using routine methods (e.g., mammography and/or ultrasound assessment) receivedDWI.Inthecaseofpre-menopausalwomen, the procedure was performed between the 4 th and 12 th days of the menstrual cycle, to avoid potential differences in uptake of the contrast agent in the glandular tissue of the breast [14, 15] . MRI brings anumberofbenefitstobreastimaging,andpresently the list of indications includes: screening of high risk individuals (e.g., women with a family history [22] .Despitethisconfidence,thelocalizationofbenignlesionsofthebreastonADCmapsmayremain challenging due to poor contrast with surrounding glandulartissue.
Tosummarize,ADCisausefulparametertodifferentiatebenignandmalignantlesionsofthebreast. Over recent years, the obstacles that previously impededthetransferofthistechniqueintoclinicalpracticehavebeenovercome,andsignificantprogresshas beenmade,particularlyintermsofguidelines,proceduralstandardization,andMRI-guidedinterventions [23, 24] . Given the ease with which the technique couldbeintroduced,andthefactthatitwouldtake relativelylittleadditionaltime,ADCcombinedwith dynamic studies may improve the efficacy of MRI studies in the characterization of problematic breast lesions. 
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